Tokyo, Oct. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063253) titled 'Long-term Follow-up Study of SUPPRESS-AF: Efficacy and Safety of Low-voltage Guided Ablation for Recurrence Prevention Compared to Pulmonary Vein Isolation Alone in Patients with Persistent Atrial Fibrillation' on Oct. 14.
Study Type:
Observational
Primary Sponsor:
Institute - Department of Cardiovascular Medicine, The University of Osaka Graduate School of Medicine
Condition:
Condition - Persistent atrial fibrillation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the long-term effects of catheter ablation targeting left atrial low-voltage areas in addition to pulmonary vein isolation on atrial fibrillation recurrence and clinical outcomes in patients with persistent atrial fibrillation
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients enrolled in the SUPPRESS-AF study who underwent their first catheter ablation for persistent atrial fibrillation and were eligible for participation in the long-term follow-up study under the ethics committee-approved consent procedures.
Key exclusion criteria - No additional exclusion criteria are specified for this long-term follow-up study.
Target Size - 1347
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 02 Month 05 Day
Date of IRB - 2026 Year 02 Month 10 Day
Anticipated trial start date - 2026 Year 11 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072399
Disclaimer: Curated by HT Syndication.
